杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 4 2021

Full Issue

Herd Immunity Debate Flares As Experts Warn It Will Be Tough To Achieve

Following a report published by The New York Times about the shifting views of public health experts about the state of the pandemic, other news outlets examine what it means if the U.S. can not reach the mark. President Joe Biden also commented.

There is a growing belief among scientists that the U.S. will not achieve 鈥榟erd immunity鈥 when it comes to the coronavirus and there will be new flare-ups for the foreseeable future, but becoming less of a threat to the public. The New York Times reported that the reason is that the virus is mutating at a faster rate than vaccine jabs are being given. Rustom Antia, an evolutionary biologist at Emory University, told the paper that the virus is "unlikely to go away." (DeMarche, 5/4)

The New York Times' Original Story:

U.S. President Joe Biden on Tuesday will update the country on how it is faring in the battle against COVID-19 and the effort to get more Americans vaccinated against the coronavirus. The president, following remarks on Monday afternoon at a community college in Virginia, was asked by a reporter when the country will reach herd immunity 鈥 meaning, when will a sufficient percentage of the population be immune to the coronavirus that causes COVID-19 because of previous exposure or inoculation. "There鈥檚 a debate about what constitutes herd immunity," he said. "Is it 70 percent, 68 percent, 81 percent?鈥 (Herman, 5/3)

And experts weigh in 鈥

Millions of Americans are receiving Covid-19 vaccine doses every day, but one medical expert thinks the nation may not reach herd immunity this year if more people can't be persuaded to get a shot. "What I really worry about is that those people who are already on the fence don't聽get vaccinated (and) we don't聽reach herd immunity come the fall," CNN medical analyst Dr. Leana Wen told CNN. "And then with the winter ... we have a big resurgence, maybe we have variants coming in from other countries, and we could start this whole process all over again and have another huge pandemic come the winter." (Ellis and Maxouris, 5/4)

It may not take true "herd immunity" to see a dramatic drop in COVID-19 cases. Some researchers say another 30 to 40 million first shots could聽be enough for the聽United States to reach a vaccine tipping point and containment of the disease caused by the coronavirus. "It's just another 10% to 15% more people,"聽said Dr. Eric Topol, a professor of molecular medicine at the Scripps Research Institute in La Jolla, California. (Weise, 5/4)

If you鈥檙e alarmed after reading that public experts are saying the United States isn鈥檛 likely to reach herd immunity with COVID-19, Dr. Ashish Jha has a message for you. 鈥淭his is not tragic,鈥 the dean of the Brown University School of Public Health wrote on Twitter Monday. The doctor said many are misunderstanding the recent New York Times article that examines the predictions from experts on the herd immunity threshold in the United States 鈥 the point when enough Americans would be protected from the virus to make person-to-person spread of the disease unlikely. (Dwyer, 5/3)

As with any disease, how many people need to be immune to provide community protection depends on how infectious it is. For Covid-19, experts think the magic number could be anywhere between 70 to 90% of a population immune to the virus. The world is nowhere near that level. (Christensen, 5/3)

A year after the United States came under the grip of the coronavirus it should be clear that, no, the universal sacrifice from a pandemic did not bring the nation together as some suggested it might. It only made the nation more polarized politically and culturally. And now something else should be evident: An emerging but striking divide in vaccination rates among red and blue states could mean the coronavirus and the political division that comes with it are going to stick around for a while. (Pindell, 5/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 15
  • Friday, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
  • Monday, June 8
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF